Skip to main content
EJNMMI Research

Table 1 Subject’s age, bodyweight, injected dose of 18F-FDG, and uptake time: means ± standard deviation

From: What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours

 

All patients

NHL

HL

Sarcoma

Age, years

10.33 ± 4.97

[1–17]

9.8 ± 5.0

13.1 ± 3.7

8.7 ± 5.2

Bodyweight, kg

38.50 ± 20.69

[7.0–89.5]

36.3 ± 20.3

49.9 ± 15.4

32.2 ± 21.9

18F-FDG dose, MBq

134.97 ± 53.65

[41–246]

129.8 ± 51.8

155.1 ± 40.9

124.3 ± 62.0

Uptake time, min

70.14 ± 16.94

[46–126]

69.0 ± 12.7

59.9 ± 7.4

78.7 ± 21.7

  1. NHL non-Hodgkin lymphoma, HL Hodgkin lymphoma. Uptake time: time between PET tracer injection and the beginning of imaging in minutes
Back to article page